Published in Proc Natl Acad Sci U S A on February 08, 2008
Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A (2008) 2.80
Malaria biology and disease pathogenesis: insights for new treatments. Nat Med (2013) 2.38
High plasma erythropoietin levels are associated with prolonged coma duration and increased mortality in children with cerebral malaria. Clin Infect Dis (2014) 2.02
Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J (2008) 2.00
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res (2010) 1.98
Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One (2011) 1.55
Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol (2009) 1.50
Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study. PLoS One (2010) 1.43
Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics (2009) 1.36
Dysregulation of coagulation in cerebral malaria. Mol Biochem Parasitol (2009) 1.29
Hemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesis. PLoS Pathog (2013) 1.22
Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther (2010) 1.20
Host control of malaria infections: constraints on immune and erythropoeitic response kinetics. PLoS Comput Biol (2008) 1.05
CXCL4 and CXCL10 predict risk of fatal cerebral malaria. Dis Markers (2011) 1.00
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India. Malar J (2011) 0.99
CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin. Am J Pathol (2011) 0.97
Potential biomarkers and their applications for rapid and reliable detection of malaria. Biomed Res Int (2014) 0.96
Schistosoma mansoni infection reduces the incidence of murine cerebral malaria. Malar J (2010) 0.94
Induction of the vascular endothelial growth factor pathway in the brain of adults with fatal falciparum malaria is a non-specific response to severe disease. Histopathology (2010) 0.93
Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward? J Investig Med (2011) 0.92
Platelets alter gene expression profile in human brain endothelial cells in an in vitro model of cerebral malaria. PLoS One (2011) 0.92
The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria. Malar J (2011) 0.91
Macrophage migration inhibitory factor is associated with mortality in cerebral malaria patients in India. BMC Res Notes (2009) 0.88
On Programmed Cell Death in Plasmodium falciparum: Status Quo. J Trop Med (2012) 0.88
Apoptosis induced by parasitic diseases. Parasit Vectors (2010) 0.88
Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria. Malar J (2009) 0.87
Erythropoietin treatment alleviates ultrastructural myelin changes induced by murine cerebral malaria. Malar J (2012) 0.87
Molecular correlates of experimental cerebral malaria detectable in whole blood. Infect Immun (2010) 0.86
Platelet activation determines angiopoietin-1 and VEGF levels in malaria: implications for their use as biomarkers. PLoS One (2013) 0.86
Potential serological biomarkers of cerebral malaria. Dis Markers (2011) 0.85
Evidence of promiscuous endothelial binding by Plasmodium falciparum-infected erythrocytes. Cell Microbiol (2014) 0.84
The pathophysiology of malarial anaemia: where have all the red cells gone? BMC Med (2008) 0.84
Systemic and Cerebral Vascular Endothelial Growth Factor Levels Increase in Murine Cerebral Malaria along with Increased Calpain and Caspase Activity and Can be Reduced by Erythropoietin Treatment. Front Immunol (2014) 0.84
Vasospasm in cerebral inflammation. Int J Inflam (2014) 0.84
Cerebral tissue oxygenation impairment during experimental cerebral malaria. Virulence (2013) 0.83
The evidence for a role of vasospasm in the pathogenesis of cerebral malaria. Malar J (2015) 0.82
Erythropoietin protects against murine cerebral malaria through actions on host cellular immunity. Infect Immun (2013) 0.82
Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis. Ther Adv Neurol Disord (2008) 0.82
Protective or pathogenic effects of vascular endothelial growth factor (VEGF) as potential biomarker in cerebral malaria. Pathog Glob Health (2014) 0.81
Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia. Southeast Asian J Trop Med Public Health (2008) 0.81
Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches. Front Cell Infect Microbiol (2015) 0.78
The Roles of Mast Cells in Parasitic Protozoan Infections. Front Immunol (2017) 0.78
Effects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparum. Malar J (2014) 0.77
Erythropoietin Levels Increase during Cerebral Malaria and Correlate with Heme, Interleukin-10 and Tumor Necrosis Factor-Alpha in India. PLoS One (2016) 0.75
Host Biomarkers Are Associated With Response to Therapy and Long-Term Mortality in Pediatric Severe Malaria. Open Forum Infect Dis (2016) 0.75
Pathogenic CD8(+) T Cells Cause Increased Levels of VEGF-A in Experimental Malaria-Associated Acute Respiratory Distress Syndrome, but Therapeutic VEGFR Inhibition Is Not Effective. Front Cell Infect Microbiol (2017) 0.75
A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria. Mol Neurobiol (2016) 0.75
Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet (1997) 13.64
Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med (1989) 10.29
Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med (1989) 6.79
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A (2000) 5.20
Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J (2002) 4.75
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest (2000) 4.36
Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science (2004) 4.09
Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med (2002) 3.87
Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem (1996) 3.80
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A (2001) 3.80
Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther (1998) 3.57
Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol (2005) 3.54
In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A (1998) 3.53
Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med (1992) 3.30
Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry (2005) 3.28
Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke (1997) 3.26
Neurological sequelae of cerebral malaria in children. Lancet (1990) 3.11
Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. Lancet (2001) 2.78
Intracranial pressure in African children with cerebral malaria. Lancet (1991) 2.67
From angiogenesis to neuropathology. Nature (2005) 2.56
Increased prevalence of epilepsy associated with severe falciparum malaria in children. Epilepsia (2004) 2.53
Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med (2003) 2.37
Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci (2005) 2.32
Developmental impairments following severe falciparum malaria in children. Trop Med Int Health (2005) 2.13
Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J Infect Dis (2006) 2.06
Severe anaemia in children living in a malaria endemic area of Kenya. Trop Med Int Health (1997) 2.05
A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem (1994) 2.03
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem (2005) 1.95
Risk factors for persisting neurological and cognitive impairments following cerebral malaria. Arch Dis Child (2005) 1.85
Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood (2006) 1.83
Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem (1996) 1.81
High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention. J Am Coll Cardiol (2005) 1.66
Epilepsy as a consequence of cerebral malaria in area in which malaria is endemic in Mali, West Africa. Epilepsia (2006) 1.45
Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol (2001) 1.41
Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol (1997) 1.41
Erythropoietin and the hypoxic brain. J Exp Biol (2004) 1.37
Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol (2006) 1.32
Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J Neurosci Res (2002) 1.24
Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci U S A (2002) 1.22
Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword. Adv Exp Med Biol (2004) 1.17
Angiogenic proteins in brains of patients who died with cerebral malaria. J Neuroimmunol (2003) 1.15
Manifestations, quality of emergency care and outcome of severe malaria in Mulago Hospital, Uganda. Afr Health Sci (2004) 1.09
Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoietin production by reactive oxygen species. Kidney Int (1997) 1.09
Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro. J Neurochem (2006) 1.08
Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex. Neurol Res (2005) 1.00
Age-related changes in adaptation to severe anemia in childhood in developing countries. Proc Natl Acad Sci U S A (2007) 0.97
Management of severe falciparum malaria. J Postgrad Med (2004) 0.97
Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat. Brain Res (2006) 0.94
Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci (2004) 0.91
Iron chelating agents for treating malaria. Cochrane Database Syst Rev (2003) 0.89
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet (2008) 8.50
Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet (2012) 4.31
Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol (2005) 3.54
Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study. BMJ (2005) 3.34
Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA (2006) 3.31
Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens. BMC Public Health (2006) 3.01
HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis (2009) 2.80
Increased prevalence of epilepsy associated with severe falciparum malaria in children. Epilepsia (2004) 2.53
Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics (2007) 2.47
Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics (2008) 2.45
Response to volume resuscitation in children with severe malaria. Pediatr Crit Care Med (2003) 2.39
Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome. Br J Haematol (2002) 2.39
Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya. Blood (2005) 2.35
Malarial anemia: of mice and men. Blood (2007) 2.27
Defining childhood severe falciparum malaria for intervention studies. PLoS Med (2007) 2.22
Can erythropoietin be used to prevent brain damage in cerebral malaria? Trends Parasitol (2008) 2.19
Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malar J (2009) 2.19
Children with severe malnutrition: can those at highest risk of death be identified with the WHO protocol? PLoS Med (2006) 2.16
Developmental impairments following severe falciparum malaria in children. Trop Med Int Health (2005) 2.13
An immune basis for malaria protection by the sickle cell trait. PLoS Med (2005) 2.08
Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians. Am J Trop Med Hyg (2007) 2.08
Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure. Genes Dev (2013) 1.99
The effect of Plasmodium falciparum on cognition: a systematic review. Trop Med Int Health (2006) 1.96
Hypothetical performance of syndrome-based management of acute paediatric admissions of children aged more than 60 days in a Kenyan district hospital. Bull World Health Organ (2003) 1.87
Plasmodium falciparum var gene expression is modified by host immunity. Proc Natl Acad Sci U S A (2009) 1.86
Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood (2006) 1.83
Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis (2006) 1.79
Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya. Clin Infect Dis (2009) 1.74
Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PLoS One (2011) 1.71
Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg (2008) 1.69
Malaria and the red cell. Hematology Am Soc Hematol Educ Program (2002) 1.64
Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis (2009) 1.63
Acute bacterial meningitis in children admitted to a rural Kenyan hospital: increasing antibiotic resistance and outcome. Pediatr Infect Dis J (2002) 1.60
Global gene expression analysis of human erythroid progenitors. Blood (2011) 1.59
Incidence and outcome of convulsive status epilepticus in Kenyan children: a cohort study. Lancet Neurol (2008) 1.55
Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial. PLoS Clin Trials (2006) 1.55
Neuro-cognitive impairment following acquired central nervous system infections in childhood: a systematic review. Brain Res Brain Res Rev (2003) 1.52
Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol (2009) 1.50
Indicators of acute bacterial meningitis in children at a rural Kenyan district hospital. Pediatrics (2004) 1.49
The role of weight for age and disease stage in poor psychomotor outcome of HIV-infected children in Kilifi, Kenya. Dev Med Child Neurol (2009) 1.48
The origin of faeces by means of biomarker detection. Environ Int (2002) 1.48
Selective depletion of FOXP3(high) cells by Fas-Fas-L-induced apoptosis occurs in CD4(+)CD25(+)-enriched populations during repeated expansion. Cytotherapy (2013) 1.39
The incidence, aetiology and outcome of acute seizures in children admitted to a rural Kenyan district hospital. BMC Pediatr (2008) 1.36
Severe falciparum malaria and acquired childhood language disorder. Dev Med Child Neurol (2006) 1.35
Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect Immun (2005) 1.30
Seizures in 204 comatose children: incidence and outcome. Intensive Care Med (2012) 1.30
Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles. Sci Transl Med (2012) 1.27
Socioeconomic predictors of cognition in Ugandan children: implications for community interventions. PLoS One (2009) 1.25
The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa. Am J Trop Med Hyg (2004) 1.24
GPVI levels in platelets: relationship to platelet function at high shear. Blood (2003) 1.23
Pre-transfusion management of children with severe malarial anaemia: a randomised controlled trial of intravascular volume expansion. Br J Haematol (2005) 1.23
Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors. PLoS One (2009) 1.21
Neurological and developmental outcome of neonatal jaundice and sepsis in rural Kenya. Trop Med Int Health (2005) 1.21
Acidosis of severe falciparum malaria: heading for a shock? Trends Parasitol (2005) 1.20
Survival and haematological recovery of children with severe malaria transfused in accordance to WHO guidelines in Kilifi, Kenya. Malar J (2008) 1.19
Malaria, monocytes, macrophages and myeloid dendritic cells: sticking of infected erythrocytes switches off host cells. Curr Opin Immunol (2002) 1.16
Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity. J Infect Dis (2005) 1.14
Platelet-induced autoagglutination of Plasmodium falciparum-infected red blood cells and disease severity in Thailand. J Infect Dis (2004) 1.12
Invasive bacterial infections in neonates and young infants born outside hospital admitted to a rural hospital in Kenya. Pediatr Infect Dis J (2010) 1.10
A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria. PLoS Pathog (2009) 1.09
Iron deficiency and acute seizures: results from children living in rural Kenya and a meta-analysis. PLoS One (2010) 1.08
Paediatric HIV and neurodevelopment in sub-Saharan Africa: a systematic review. Trop Med Int Health (2008) 1.07
Perturbations in electrolyte levels in kenyan children with severe malaria complicated by acidosis. Clin Infect Dis (2004) 1.07
Continuous EEG monitoring in Kenyan children with non-traumatic coma. Arch Dis Child (2012) 1.06
Clinical features, proximate causes, and consequences of active convulsive epilepsy in Africa. Epilepsia (2013) 1.03
Management of severe malaria in children: proposed guidelines for the United Kingdom. BMJ (2005) 1.03
Hepcidin demonstrates a biphasic association with anemia in acute Plasmodium falciparum malaria. Haematologica (2012) 1.03
Rehabilitation for cognitive impairments after cerebral malaria in African children: strategies and limitations. Trop Med Int Health (2006) 1.01
Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast. Brain (2011) 1.01
Impaired everyday memory associated with encephalopathy of severe malaria: the role of seizures and hippocampal damage. Malar J (2009) 1.00
Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors. Cochrane Database Syst Rev (2014) 0.99
The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial. PLoS One (2012) 0.99
Challenges in retaining research scientists beyond the doctoral level in Kenya. PLoS Negl Trop Dis (2009) 0.98
Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya. Vaccine (2008) 0.98
Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity. J Immunol (2013) 0.97
Role of viruses in Kenyan children presenting with acute encephalopathy in a malaria-endemic area. Am J Trop Med Hyg (2006) 0.97
The tympanic membrane displacement analyser for monitoring intracranial pressure in children. Childs Nerv Syst (2013) 0.96
Malaria. Curr Opin Infect Dis (2003) 0.95
The reasons for the epilepsy treatment gap in Kilifi, Kenya: using formative research to identify interventions to improve adherence to antiepileptic drugs. Epilepsy Behav (2012) 0.95
Value of Plasmodium falciparum histidine-rich protein 2 level and malaria retinopathy in distinguishing cerebral malaria from other acute encephalopathies in Kenyan children. J Infect Dis (2013) 0.94
Axonal and astrocyte injury markers in the cerebrospinal fluid of Kenyan children with severe malaria. J Neurol Sci (2007) 0.94
Mortality patterns and site heterogeneity of severe malaria in African children. PLoS One (2013) 0.94
Thrombocytopenia in falciparum malaria is associated with high concentrations of IL-10. Am J Trop Med Hyg (2006) 0.93
Inhibition of T cell function during malaria: implications for immunology and vaccinology. J Exp Med (2003) 0.93